H3 G34-mutant high-grade glioma
Author:
Funder
Korea Health Industry Development Institute
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Neurology (clinical),Oncology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s10014-020-00378-8.pdf
Reference26 articles.
1. Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, Van Loo P, Wedge DC, Cooke SL, Gundem G, Davies H et al (2013) Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet 45:1479–1482
2. Bjerke L, Mackay A, Nandhabalan M, Burford A, Jury A, Popov S, Bax DA, Carvalho D, Taylor KR, Vinci M et al (2013) Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCN. Cancer Discov 3:512–519
3. Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH et al (2013) The somatic genomic landscape of glioblastoma. Cell 155:462–477
4. Fang J, Huang Y, Mao G, Yang S, Rennert G, Gu L, Li H, Li GM (2018) Cancer-driving H3G34V/R/D mutations block H3K36 methylation and H3K36me3–MutSalpha interaction. Proc Natl Acad Sci USA 115:9598–9603
5. Gielen GH, Gessi M, Hammes J, Kramm CM, Waha A, Pietsch T (2013) H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas. Am J Clin Pathol 139:345–349
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Roles of Histone H2B, H3 and H4 Variants in Cancer Development and Prognosis;International Journal of Molecular Sciences;2024-09-07
2. Midline invasion predicts poor prognosis in diffuse hemispheric glioma, H3 G34-mutant: an individual participant data review;Journal of Neuro-Oncology;2024-03
3. Diffuse glioma overview based on the 2021 WHO classifi cation part 2 – pediatric type;Česká a slovenská neurologie a neurochirurgie;2024-02-29
4. Brain Tumor Imaging in Adolescents and Young Adults: 2021 WHO Updates for Molecular-based Tumor Types;Radiology;2024-02-01
5. Chimeric Antigen Receptor T Cell and Chimeric Antigen Receptor NK Cell Therapy in Pediatric and Adult High-Grade Glioma—Recent Advances;Cancers;2024-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3